|
|
Home > Healthcare > Medical > Insurance & Managed Care
Dealmaking and Industry Outlook: Geriatric Diseases
|
| Published Date:
May 2009
Published By:
Decision Resources
Page Count:
40
Order Code:
R55-641
|
|
|
|
Introduction
Rising Medicare costs driven by the aging baby boomers will, within the next few years, propel public national health expenditures in the United States above private national health expenditures for the first time ever.
Increasing expenditures are just one of the healthcare consequences of the rapidly growing elderly demographic in most countries—as people live longer, the costs associated with increased life span grow. Demand for drug treatments that serve this growing cohort is also on the rise. Almost certainly, better drugs and healthcare will be developed to address this important segment of global markets. This report covers therapeutic areas that have the greatest effect on the geriatric population (including cardiology, metabolic, neurology, and respiratory areas) through 25 data-rich figures and tables, as well as insights from Decision Resources analysts.
Questions Answered in This Report
- Most personal health expenditures in the United States are spent on indications that greatly affect the elderly.
What are these therapeutic indications? How much money do U.S. residents spend on these indications?
- The seven major markets differ in their prescription drug coverage. How do these countries cover their elderly?
Do markets other than the U.S. market offer healthcare coverage specifi c to the elderly population?
- Current treatments for diseases afflicting the elderly have advantages and disadvantages. What are the opinions
of Decision Resources analysts regarding these treatments? What are the most promising treatments?
What characteristics of geriatric patients should drug developers consider when targeting this segment?
Scope
- Population demographics: past, current, and projected elderly populations; life expectancy in the
major markets; life expectancy in the United States.
- U.S. healthcare expenditures: total healthcare expenditures, healthcare expenditures as a percentage
of GDP, sources of healthcare expenditure.
- Therapeutic areas affecting the elderly: cardiovascular, metabolic, respiratory, musculoskeletal, central
nervous system, genitourinary, ophthalmology, oncology.
- Deals affecting companies making drugs that serve the elderly population: cardiovascular, diabetes,
respiratory, central nervous system, ophthalmology, osteoporosis, and osteoarthritis.
|
Similar Products
• H4-13, Market Access, Pricing, and Reimbursement News in the Third Quarter of 2009
Published Oct 2009 by Decision Resources
• Xerox Acquisition of ACS: Implications for the Healthcare Payer Market
Published Oct 2009 by IDC
• Australian Public Sector: Medicare Australia
Published Oct 2009 by Ovum Plc
• Dell and Perot Systems: Implications for the Healthcare Market
Published Oct 2009 by IDC
• Health & Welfare Funds in the US - Industry Risk Rating Report
Published Oct 2009 by IBISWorld
• Plunkett's Health Care Industry Trends and Statistics 2010 (Summary)
Published Oct 2009 by Plunkett Research, Ltd.
• Plunkett's Health Care Industry Almanac 2010
Published Oct 2009 by Plunkett Research, Ltd.
• 2010 U.S. Health & Medical Insurance Carriers Industry Report
Published Oct 2009 by Barnes Reports
• Express Scripts, Inc.
Published Oct 2009 by SGA Lists
|
|
|
|
0 items
